CE vs CGEM · rev $10.28B vs $830.3M cap
Celanese Corporation (CE) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
CE currently screens at market cap $5.92B. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the CE and CGEM stock pages for the full models.
Not investment advice.